Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

BACKGROUND: Optimal management for recurrent IDH-mutant glioma after radiation therapy (RT) is not well-defined. This study assesses practice patterns for managing recurrent IDH-mutant astrocytoma (Astro) and 1p/19q codeleted oligodendroglioma (Oligo) after RT and surveys their clinical outcomes aft...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurooncol Adv
Hauptverfasser: Ma, Sirui, Rudra, Soumon, Campian, Jian L, Chheda, Milan G, Johanns, Tanner M, Ansstas, George, Abraham, Christopher D, Chicoine, Michael R, Leuthardt, Eric C, Dowling, Joshua L, Dunn, Gavin P, Kim, Albert H, Huang, Jiayi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Clinical Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8324173/
https://ncbi.nlm.nih.gov/pubmed/34345818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab081
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge